|

Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency

RECRUITINGSponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche
Actively Recruiting
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
Started2023-06-12
Est. completion2030-05
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05871164

Summary

The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 18 years old;
* Patient to be treated for a pancreatic tumor by ultrasound-guided RF with a fine needle;
* Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting;
* Patient able to understand the information related to the study;
* Patient accepting study follow-up visits;
* Patient having been informed and agreeing to participate in the study.

Exclusion Criteria:

* Patient with a contraindication to radiofrequency treatment;
* Pregnant or breastfeeding women

Conditions2

CancerPancreatic Tumor

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.